Arena Pharmaceuticals, Inc.
CEO
Amit Munshi
IPO Date
2000-07-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Arena (ARNA) Starts Phase II Study on Coronary Drug Temanogrel
Arena Pharmaceuticals Announces Orphan Drug Designation for Etrasimod for the Treatment of Eosinophilic Esophagitis (EoE)
Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi on Q1 2021 Results - Earnings Call Transcript
Arena Pharmaceuticals, Inc. (ARNA) Reports Q1 Loss, Misses Revenue Estimates
Arena Pharmaceuticals, Inc. (ARNA) Down 12.2% Since Last Earnings Report: Can It Rebound?
3 Reasons to Avoid Arena Pharmaceuticals -- and 1 Reason to Buy
Arena (ARNA) Q4 Earnings Miss Estimates, Pipeline Progresses